[
    {
        "role": "user",
        "content": "Study effectiveness and safety of Farxiga (Dapagliflozin) in Type 2 Diabetes Mellitus Management for senior population."
    },
    {
        "role": "assistant",
        "content": "I need some clarification to better understand your research needs:",
        "questions": [
            "Are there specific cardiovascular, renal, or glycemic outcomes of particular interest when evaluating the effectiveness of Farxiga in elderly T2DM patients?",
            "Is the target audience for this research other researchers, clinicians, policymakers, or patients, and how will this influence the level of detail required?",
            "Beyond efficacy and adverse events, should the research also consider patient-reported outcomes, quality of life, or healthcare costs associated with Farxiga use in this population?",
            "Are there any specific subgroups within the senior population (e.g., based on age, comorbidities, frailty) that should be prioritized in the analysis?",
            "Are you interested in comparing Farxiga to specific alternative treatments or standard care approaches currently used in elderly T2DM patients?"
        ]
    },
    {
        "role": "user",
        "content": "I approve this research plan."
    },
    {
        "role": "assistant",
        "content": "Thank you! I'll start the research process now. You can see my progress on the right panel."
    }
]

----------------

{
    "detail": [
        {
            "type": "missing",
            "loc": [
                "body",
                "chat_history"
            ],
            "msg": "Field required",
            "input": {
                "research_id": "b70727e4-c03f-4ae8-8227-81bf56e5c0d3",
                "version": "khkqwhek9873912739",
                "messages": [
                    {
                        "role": "user",
                        "content": "Study effectiveness and safety of Farxiga (Dapagliflozin) in Type 2 Diabetes Mellitus Management for senior population."
                    },
                    {
                        "role": "assistant",
                        "content": "I need some clarification to better understand your research needs:",
                        "questions": [
                            "Are there specific cardiovascular, renal, or glycemic outcomes of particular interest when evaluating the effectiveness of Farxiga in elderly T2DM patients?",
                            "Is the target audience for this research other researchers, clinicians, policymakers, or patients, and how will this influence the level of detail required?",
                            "Beyond efficacy and adverse events, should the research also consider patient-reported outcomes, quality of life, or healthcare costs associated with Farxiga use in this population?",
                            "Are there any specific subgroups within the senior population (e.g., based on age, comorbidities, frailty) that should be prioritized in the analysis?",
                            "Are you interested in comparing Farxiga to specific alternative treatments or standard care approaches currently used in elderly T2DM patients?"
                        ]
                    },
                    {
                        "role": "user",
                        "content": "I approve this research plan."
                    },
                    {
                        "role": "assistant",
                        "content": "Thank you! I'll start the research process now. You can see my progress on the right panel."
                    }
                ]
            }
        }
    ]
}
----------------------

[
    {
        "type": "missing",
        "loc": [
            "body",
            "research_id"
        ],
        "msg": "Field required",
        "input": {
            "version": "1",
            "chat_history": [
                {
                    "role": "user",
                    "content": "Study effectiveness and safety of Farxiga (Dapagliflozin) in Type 2 Diabetes Mellitus Management for senior population."
                },
                {
                    "role": "assistant",
                    "content": "I need some clarification to better understand your research needs:",
                    "questions": [
                        "Are there specific cardiovascular, renal, or other co-morbid conditions within the senior T2DM population that the research should prioritize?",
                        "Is the primary outcome of interest HbA1c reduction, hospitalization rates, adverse events, or a combination of factors?",
                        "What is the preferred study design: randomized controlled trial, observational study, meta-analysis, or other?",
                        "Are there specific subgroups within the senior population (e.g., based on age, frailty, cognitive function) that should be analyzed separately?",
                        "Are there specific safety concerns or drug interactions unique to seniors taking dapagliflozin that the research should address?"
                    ]
                },
                {
                    "role": "user",
                    "content": "I approve this research plan."
                },
                {
                    "role": "assistant",
                    "content": "Thank you! I'll start the research process now. You can see my progress on the right panel."
                }
            ]
        }
    },
    {
        "type": "string_type",
        "loc": [
            "body",
            "chat_history",
            0
        ],
        "msg": "Input should be a valid string",
        "input": {
            "role": "user",
            "content": "Study effectiveness and safety of Farxiga (Dapagliflozin) in Type 2 Diabetes Mellitus Management for senior population."
        }
    },
    {
        "type": "string_type",
        "loc": [
            "body",
            "chat_history",
            1
        ],
        "msg": "Input should be a valid string",
        "input": {
            "role": "assistant",
            "content": "I need some clarification to better understand your research needs:",
            "questions": [
                "Are there specific cardiovascular, renal, or other co-morbid conditions within the senior T2DM population that the research should prioritize?",
                "Is the primary outcome of interest HbA1c reduction, hospitalization rates, adverse events, or a combination of factors?",
                "What is the preferred study design: randomized controlled trial, observational study, meta-analysis, or other?",
                "Are there specific subgroups within the senior population (e.g., based on age, frailty, cognitive function) that should be analyzed separately?",
                "Are there specific safety concerns or drug interactions unique to seniors taking dapagliflozin that the research should address?"
            ]
        }
    },
    {
        "type": "string_type",
        "loc": [
            "body",
            "chat_history",
            2
        ],
        "msg": "Input should be a valid string",
        "input": {
            "role": "user",
            "content": "I approve this research plan."
        }
    },
    {
        "type": "string_type",
        "loc": [
            "body",
            "chat_history",
            3
        ],
        "msg": "Input should be a valid string",
        "input": {
            "role": "assistant",
            "content": "Thank you! I'll start the research process now. You can see my progress on the right panel."
        }
    }
]
